{
    "Trade/Device Name(s)": [
        "ACON BUP One Step Buprenorphine Test Strip",
        "ACON BUP One Step Buprenorphine Test Device"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K060466",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "February 21, 2006",
    "Summary Letter Received Date": "February 22, 2006",
    "Submission Date": "February 21, 2006",
    "Regulation Number(s)": [
        "21CFR862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Buprenorphine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Competitive binding",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Strip test",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for ACON BUP One Step Buprenorphine Test Strip and Device, qualitative urine immunoassay for buprenorphine drug compliance screening",
    "Indications for Use Summary": "Rapid chromatographic immunoassays for qualitative detection of Buprenorphine in human urine at 10 ng/mL cutoff, used by healthcare professionals including point-of-care for drug compliance determination; preliminary results require confirmatory testing.",
    "fda_folder": "Toxicology"
}